magnolol has been researched along with Cancer of Prostate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catalli, A; Hurta, RA; McDougall, L; McKeown, BT | 1 |
| Hurta, RA; McKeown, BT | 1 |
| Lee, DH; Lee, YJ; Szczepanski, MJ | 1 |
| Hwang, ES; Park, KK | 1 |
4 other study(ies) available for magnolol and Cancer of Prostate
| Article | Year |
|---|---|
Magnolol causes alterations in the cell cycle in androgen insensitive human prostate cancer cells in vitro by affecting expression of key cell cycle regulatory proteins.
Topics: Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cyclin A; Cyclin B1; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p27; Humans; Lignans; Magnolia; Male; Plant Extracts; Prostatic Neoplasms | 2014 |
Magnolol affects expression of IGF-1 and associated binding proteins in human prostate cancer cells in vitro.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biphenyl Compounds; Blotting, Western; Humans; In Vitro Techniques; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Lignans; Male; Prostatic Neoplasms; Receptor, IGF Type 1; Tumor Cells, Cultured | 2014 |
Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; bcl-2-Associated X Protein; bcl-Associated Death Protein; bcl-X Protein; Biphenyl Compounds; Cell Line, Tumor; Cytochromes c; Epidermal Growth Factor; ErbB Receptors; Humans; Lignans; Male; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction | 2009 |
Magnolol suppresses metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in PC-3 human prostate carcinoma cells.
Topics: Biphenyl Compounds; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclooxygenase 1; Cyclooxygenase 2; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Lignans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Neoplasm Metastasis; Prostatic Neoplasms | 2010 |